Log in to your Inderes Free account to see all free content on this page.

SynAct Pharma

14.30 SEK

-3.77%

Less than 1K followers

SYNACT

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for SynAct Pharma

P/B

Median 2019-2025

 
2019202020212022202320242025
Share price (SEK)7.9943.70140.4680.768.758.9722.60
Shares14.924.726.229.935.946.553.3
Market cap118.91,081.23,680.82,416.3314.1416.81,205.3
Enterprise value115.31,066.63,659.82,310.2252.3357.4-
EV/S-------
EV/EBITDAneg.neg.neg.neg.neg.neg.-
EV/EBITneg.neg.neg.neg.neg.neg.-
P/Eneg.neg.neg.neg.neg.neg.neg.
P/B8.8068.14176.3719.101.781.957.08
P/S-------
Dividend yield0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %
Equity ratio56.7 %73.5 %54.4 %88.7 %77.3 %79.2 %77.2 %
Gearing ratio--14.8 %1.6 %0.4 %0.9 %0.7 %
Login required

This content is only available for logged in users